metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-84 IMPLEMENTATION OF A STEP-BY-STEP STRATEGY BASED ON THE TREATMENT CASCADE TO...
Journal Information
Vol. 24. Issue S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(September 2021)
Share
Share
Download PDF
More article options
Vol. 24. Issue S1.
Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)
(September 2021)
Open Access
P-84 IMPLEMENTATION OF A STEP-BY-STEP STRATEGY BASED ON THE TREATMENT CASCADE TO ELIMINATE HEPATITIS C VIRUS INFECTION IN THE HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS FROM URUGUAY. PRELIMINARY REPORT
Visits
529
Juan Otegui, Victoria Mainardi, Daniela Olivari, Ana Fernández, Carolina Ferreira, Solange Gerona
Servicio de Enfermedades Hepáticas, Centro Nacional Hepato-Bilio-Pancreático (UDA), Programa Nacional de Traslpante Hepático, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 24. Issue S1

Abstracts of the 2021 Annual meeting of the ALEH (Asociación Latinoamericana para el Estudio del Hígado)

More info
Background

Strategies to achieve the World Health Organization target of eliminating hepatitis C virus (HCV) infection by 2030 (diagnosis of 90% of chronically infected persons and treatment of 80%) are required.

Objectives

1)  Determinate the status of HCV infection in the Hospital Central de las Fuerzas Armadas (HCFFAA) from Uruguay

2)  Implement and evaluate a step-by-step elimination strategy.

Methods

A treatment cascade was constructed by:

A  Estimation of the number of HCV chronic infection population of the HCFFA based on Uruguay prevalence (0,7%)

B  Analyzing medical records of the Hepatology service (2000–2020).

The strategy consisted on contacting sequentially patients not cured:

1.  HCV RNA confirmed

2.  HCV antibody positive, RNA not tested

Results

1.008 chronically HCV infected people were estimated.

165 HCV antibody positive persons were detected, 30 were excluded (RNA negative).

Of the 135 left, 113 had RNA confirmation, 76 received treatments and 70 achieved sustained virological response (SVR).

Of 6 persons without SVR, 3 are currently on treatment and 3 could not be contacted.

Of 36 people RNA confirmed not treated, 20 were contacted: 10 were prescribed treatment and 10 were not candidate.

Of 22 HCV antibody positive people without RNA confirmation, 10 were contacted and RNA was requested (results pending).

Treatment prescription increased from 67 to 76% of HCV chronically infected RNA confirmed patients.

Conclusion

Strategy implementation was successful improving access to treatment.

Active testing is the next step plan to overcome the barrier of patient unawareness of HCV infection.

Full text is only aviable in PDF
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos